arrow_back Back to App

Essential Medicines: Establishing a Strategic Pharmaceutical Ingredient Reserve in the US

This act aims to create a domestic reserve of key ingredients for essential generic medicines. This ensures citizens will always have access to necessary drugs, even if foreign supplies are disrupted, enhancing the nation's health security.
Key points
A public list of essential generic medicines that must always be available will be established.
A strategic reserve of ingredients for these medicines will be created, prioritizing domestic manufacturers.
Pharmaceutical companies will find it easier to switch to reserve ingredient sources without unnecessary bureaucracy.
A plan to boost domestic production of drug ingredients will reduce reliance on imports.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_5388
Sponsor: Rep. Spanberger, Abigail Davis [D-VA-7]
Process start date: 2021-09-27
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

PREPARE ACT of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_5388.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-09-27.

What are the main provisions?

Key points include:

  • A public list of essential generic medicines that must always be available will be established.
  • A strategic reserve of ingredients for these medicines will be created, prioritizing domestic manufacturers.
  • Pharmaceutical companies will find it easier to switch to reserve ingredient sources without unnecessary bureaucracy.
  • A plan to boost domestic production of drug ingredients will reduce reliance on imports.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Spanberger, Abigail Davis [D-VA-7].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health Economy Public Investments